Weed (BUDZ) Enterprise Value (2017 - 2026)
Weed's (BUDZ) quarterly Enterprise Value came in at -$1795.0 in Q1 2026, up 42.87% year-on-year from -$1256.4 in Q1 2025, and up 94.58% quarter-over-quarter from -$33130.0 in Q4 2025.
Weed (BUDZ) Enterprise Value (2017 - 2026) Analysis & Trends
Weed's Enterprise Value history runs 10 years deep, the most recent figure standing at -$1795.0 for Q1 2026.
- On a quarterly basis, Enterprise Value rose 42.87% year-over-year to -$1795.0 in Q1 2026; TTM through Mar 2026 was -$1795.0, a 42.87% increase from a year earlier, with the FY2025 full-year figure at -$33130.0, up 79.21% from the prior year.
- Enterprise Value advanced to -$1795.0 in Q1 2026 per BUDZ's latest filing, from -$33130.0 in the prior quarter.
- Across five years, Enterprise Value topped out at -$400.0 in Q3 2025 and bottomed at -$821094.0 in Q2 2022.
- The 5-year median for Enterprise Value is -$33888.0 (2022), against an average of -$182152.4.
- Across the five-year window, Enterprise Value slumped 1506.93% in 2022 and jumped 99.17% in 2024, its largest moves.
- Year by year, Enterprise Value stood at -$315826.0 in 2022, then climbed by 8.05% to -$290409.0 in 2023, then surged by 45.13% to -$159355.0 in 2024, then jumped by 79.21% to -$33130.0 in 2025, then soared by 94.58% to -$1795.0 in 2026.
- Per Business Quant, the three latest BUDZ Enterprise Value figures stand at -$1795.0 (Q1 2026), -$33130.0 (Q4 2025), and -$400.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | -1,795.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,795.00 |
| Dec 31, 2025 | -33,130.00 |
| Sep 30, 2025 | -400.00 |
| Jun 30, 2025 | -5,350.00 |
| Mar 31, 2025 | -3,142.00 |
| Dec 31, 2024 | -159,355.00 |
| Sep 30, 2024 | -5,311.00 |
| Jun 30, 2024 | -16,745.00 |
| Mar 31, 2024 | -102,696.00 |
| Dec 31, 2023 | -290,409.00 |
| Sep 30, 2023 | -643,702.00 |
| Jun 30, 2023 | -32,469.00 |
| Mar 31, 2023 | -95,751.00 |
| Dec 31, 2022 | -315,826.00 |
| Sep 30, 2022 | -535,527.00 |
| Jun 30, 2022 | -821,094.00 |
| Mar 31, 2022 | -33,888.00 |
| Dec 31, 2021 | -19,654.00 |
| Sep 30, 2021 | -303,739.00 |
| Jun 30, 2021 | -260,602.00 |